Elicio Therapeutics Inc (ELTX)
10.35
+0.05
(+0.49%)
USD |
NASDAQ |
May 15, 14:28
Elicio Therapeutics Cash from Financing (TTM)
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2022 | 23.90M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
23.90M
Minimum
Sep 2022
23.90M
Maximum
Sep 2022
23.90M
Average
23.90M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
Immuneering Corp | 29.18M |
Outlook Therapeutics Inc | 5.120M |
Amylyx Pharmaceuticals Inc | 2.634M |
NovaBay Pharmaceuticals Inc | 1.313M |
Palatin Technologies Inc | 5.553M |